Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Statin and Antiplatelet Therapy for High-risk Intracranial or Extracranial Atherosclerosis (INSPIRES)

NCT03635749 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT03635749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03635749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Statin and Antiplatelet Therapy for High-risk Intracranial or Extracranial Atherosclerosis (INSPIRES)
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
September 17, 2018
Completion date
October 30, 2023
Enrollment
6,100 (actual)
Sites
113

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, transient ischemic attack